Meet The Under-The-Radar Immigrant Black Doctor Who Has Made A Half Billion Dollar Fortune While Revolutionizing Alzheimer’s Treatment

There’s a good chance that you know someone who is dealing with Alzheimer’s in their family. Perhaps that person is a member of your own family. In the US, there are around 6.2 million persons with Alzheimer’s disease. The symptoms of emotional discomfort can include screaming or acting violently. A whole 40% of Alzheimer’s patients require medical attention. However, despite, the fact that so many people suffer from this disease, there isn’t even one drug approved by the FDA designed to treat the agitation that is common in people with Alzheimer’s. Once the agitation becomes too much for their family members to handle, many patients with this disease are placed in long-term care. All of that will change thanks to Dr. Herriot Tabuteau.

Axsome Therapeutics, a biopharmaceutical company with headquarters in New York that created the medication AXS-05, is managed by Dr. Tabuteau. AXS-05 has been hailed as a ground-breaking treatment for Alzheimer’s disease-related agitation. Likewise, the Food and Drug Administration. Axsome began the last stage of the trials necessary to submit an application for complete FDA approval in December. According to Axsome, the drug will go on sale in 2023. Additionally, AXS-05 is regarded as a viable treatment choice for major depressive illness.

FRANCK FIFE/AFP via Getty Images

AFP/FRANCK FIFE via Getty Pictures

When he was nine years old, Dr. Herriot Tabuteau moved from Haiti to the United States. He succeeded academically while attending Xavier High School in New York City. When he was a junior in high school, he wrote a book called “How to Get A’s in School,” which was published by New York’s LBT Publishing. He earned a bachelor’s degree in molecular biology and biochemistry from Wesleyan University in 1989. He continued on to Yale School of Medicine, where he earned his M.D. in 1994. He examined the brain tissue of epileptics who had developed resistance to anti-seizure drugs for his honors thesis. His goal was to investigate GABA function, a neurotransmitter thought to be capable of preventing seizures. Tabuteau chose investment banking over becoming a neurosurgeon, contrary to the predictions of his mentors. Tabuteau, who had just received his M.D., was employed by Goldman Sachs as an analyst where he focused on healthcare analysis. Later, he worked for HealthCor, a fund that was devoted to healthcare and life sciences.

Tabuteau has a paper net worth of $465 million as of this writing because he owns 22% of the company’s outstanding shares.

He has never traded even one share of his business. He is nevertheless one of the wealthiest Black Americans according to his $465 million net worth. He avoids speaking to the media and hasn’t done so since 1998. As you might have noticed, we couldn’t even find a license-able photo of the good doctor to use in this article!

It’s always interesting to write about someone who made a fortune by helping others. Dr. Tabuteau, thank you for all you do. As you enhance innumerable lives, may your wealth increase!

Leave a Reply

Your email address will not be published.